NCT06689254View on ClinicalTrials.gov

REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism

PHASE2RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

September 15, 2026

Study Completion Date

November 15, 2026

Conditions

Treatment-resistant PTSD

Interventions

DRUG

Mifepristone 1200 mg daily

Oral tablets

DRUG

Placebo

Oral tablet

Trial Locations (1)

1018HV

RECRUITING

Amsterdam UMC, location VUmc, Amsterdam

Sponsors

Collaborators (1)

Corcept Therapeutics

All Listed Sponsors

collaborator

Corcept Therapeutics

INDUSTRY

lead

Christiaan Vinkers

OTHER